Education
About Us
Working with TipRanks
Follow Us
Khiron Life Sciences Corp (KHRNF)
OTHER OTC:KHRNF
Total Valuation
Khiron Life Sciences has a market cap or net worth of $5.25M. The enterprise value is ―.
Market Cap$5.25M
Enterprise Value―
Share Statistics
Khiron Life Sciences has 229,514,920 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding229,514,920
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
Khiron Life Sciences’s return on equity (ROE) is -0.99 and return on invested capital (ROIC) is -54.08%.
Return on Equity (ROE)-0.99
Return on Assets (ROA)-0.78
Return on Invested Capital (ROIC)-54.08%
Return on Capital Employed (ROCE)-0.57
Revenue Per Employee41.27K
Profits Per Employee-108.37K
Employee Count310
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Khiron Life Sciences is ―. Khiron Life Sciences’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value―
Price to FCF0.00
Price to Operating Cash Flow-0.32
PEG Ratio―
Income Statement
In the last 12 months, Khiron Life Sciences had revenue of 12.79M and earned -33.13M in profits. Earnings per share was -0.20.
Revenue12.79M
Gross Profit6.37M
Operating Income-19.79M
Pretax Income-33.59M
Net Income-33.13M
EBITDA-32.03M
Earnings Per Share (EPS)-0.20
Cash Flow
In the last 12 months, operating cash flow was -15.01M and capital expenditures -2.78M, giving a free cash flow of -17.80M billion.
Operating Cash Flow-15.01M
Free Cash Flow-17.80M
Free Cash Flow per Share-0.08
Dividends & Yields
Khiron Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-3408.63
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Khiron Life Sciences upcoming earnings date is Nov 29, 2023, TBA (Confirmed).
Last Earnings DateAug 28, 2023
Next Earnings DateNov 29, 2023
Ex-Dividend Date―
Financial Position
Khiron Life Sciences as a current ratio of ―, with Debt / Equity ratio of 6.68%
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA0.21
Interest Coverage Ratio―
Taxes
In the past 12 months, Khiron Life Sciences has paid -465.00K in taxes.
Income Tax-465.00K
Effective Tax Rate―
Enterprise Valuation
Khiron Life Sciences EV to EBITDA ratio is -0.86, with an EV/FCF ratio of -1.25.
EV to Sales2.16
EV to EBITDA-0.86
EV to Free Cash Flow-1.25
EV to Operating Cash Flow-1.35
Balance Sheet
Khiron Life Sciences has $1.94M in cash and marketable securities with ― in debt, giving a net cash position of -$626.00K billion.
Cash & Marketable Securities$1.94M
Total Debt―
Net Cash-$626.00K
Net Cash Per Share>-$0.01
Tangible Book Value Per Share―
Margins
Gross margin is 22.47%, with operating margin of ―, and net profit margin of ―.
Gross Margin22.47%
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Khiron Life Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―